Clinical Trials Browser

Phase EARLY_PHASE1 × INDUSTRY × Has results × Clear all

NCT03433898 2025-12-19

This Study Aims to Find a Safe and Effective Dose of BI 754091. The Study Also Aims to Find Safe and Effective Doses of BI 754091 and BI 754111 in Combination. This Study is Done in Asian Patients With Different Types of Cancer

Phase EARLY_PHASE1 Completed

146 enrolled 25 charts

Neoplasms

NCT03514121 2024-11-22

FPA150-001

Phase EARLY_PHASE1 Terminated

95 enrolled 36 charts

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT03564782 2024-02-08

Examining Bioactivity of PVSRIPO in Invasive Breast Cancer

Phase EARLY_PHASE1 Completed

5 enrolled 6 charts

Invasive Breast Cancer

NCT03224819 2023-09-01

Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Phase EARLY_PHASE1 Terminated

46 enrolled 40 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03655756 2022-08-08

pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma

Phase EARLY_PHASE1 Completed

7 enrolled 9 charts

Melanoma

NCT03291379 2021-07-19

VEROnA

Phase EARLY_PHASE1 Completed

8 enrolled 15 charts

Gastrointestinal

Carcinoma, Hepatocellular, Colorectal Neoplasms

NCT04223635 2021-06-22

Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants

Phase EARLY_PHASE1 Completed

16 enrolled 22 charts

Giant Cell Tumor of Tendon Sheath

NCT03592121 2020-03-12

Study to Investigate the Effect of AB-101 in Breast Cancer Survivors

Phase EARLY_PHASE1 Completed

3 enrolled 6 charts

Breast Neoplasms, Sexual Dysfunction, Physiological, Sexual Dysfunctions, Psychological